Method of classifying gene expression strength in lung cancer tissues

Abstract

The present invention provides a method of confirming the gene expression, useful in the decision of a five year survival rate of a patient with lung cancer and the use of a DNA probe kit in the method. A method useful in the decision of a survival rate of a patient with non-small cell lung cancer comprising confirming the expression strength of at least one gene in lung cancer tissues isolated from the patient.

1 . (canceled) 
     
     
         2 . A method for predicting a survival rate of a patient with non-squamous cell lung cancer comprising confirming the expression strength of at least one gene selected from the group consisting of SEQ ID NO: 9, SEQ ID NO: 1, SEQ ID NO: 6, SEQ ID NO: 56, SEQ ID NO: 57, SEQ ID NO: 58, SEQ ID NO: 20, SEQ ID NO: 59, SEQ ID NO: 60, SEQ ID NO: 11, SEQ ID NO: 61, SEQ ID NO: 7, SEQ ID NO: 62, SEQ ID NO: 2, SEQ ID NO: 63, SEQ ID NO: 14, SEQ ID NO: 21, SEQ ID NO: 64, SEQ ID NO: 65, SEQ ID NO: 66, SEQ ID NO: 67, SEQ ID NO: 68, SEQ ID NO: 69, SEQ ID NO: 70, SEQ ID NO: 71, SEQ ID NO: 5, SEQ ID NO: 72, SEQ ID NO: 18, SEQ ID NO: 73 and SEQ ID NO: 14 in lung cancer tissues isolated from the patient.